These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36361255)

  • 1. An Evaluation of Non-Communicable Diseases and Risk Factors Associated with COVID-19 Disease Severity in Dubai, United Arab Emirates: An Observational Retrospective Study.
    Al Bastaki NA; Sheek-Hussein M; Shukla A; Al-Bluwi N; Saddik B
    Int J Environ Res Public Health; 2022 Nov; 19(21):. PubMed ID: 36361255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological and Clinical Characteristics Associated with COVID-19 Severity Among Hospitalized Patients in the United Arab Emirates: A Retrospective Multicentre Study.
    Al-Bluwi N; Agha R; Shukla A; Zeidan RK; AlZubaidi H; Awad M; Hussein A; Abdelbagi M; AlSayed K; Alebaji MB; Shaheen M; Salameh L; Mahboub B; Elkhodary H; Bendardaf R; Mohammed G; Wardat D; Al-Hano Z; Amara HI; Alhajjaj MS; Hamid Q; Halwani R; Saddik B
    J Epidemiol Glob Health; 2024 Jun; 14(2):349-362. PubMed ID: 38407717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Disease Severity and Death in Relation to Vitamin D Status among SARS-CoV-2-Positive UAE Residents.
    AlSafar H; Grant WB; Hijazi R; Uddin M; Alkaabi N; Tay G; Mahboub B; Al Anouti F
    Nutrients; 2021 May; 13(5):. PubMed ID: 34069412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features of COVID-19 in Ghana: symptomatology, illness severity and comorbid non-communicable diseases.
    Oduro-Mensah E; Tetteh J; Adomako I; Adjei-Mensah E; Owoo C; Yawson AO; Oliver-Commey JA; Puplampu P; Samba A; Yawson AE; Lartey M;
    Ghana Med J; 2020 Dec; 54(4 Suppl):23-32. PubMed ID: 33976438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and early preventive measures for long COVID in non-hospitalized patients: analysis of a large cohort in the United Arab Emirates.
    Saheb Sharif-Askari F; Ali Hussain Alsayed H; Saheb Sharif-Askari N; Saddik B; Al Sayed Hussain A; Halwani R
    Public Health; 2024 May; 230():198-206. PubMed ID: 38574425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of, and factors associated with health supplement use in Dubai, United Arab Emirates: a population-based cross-sectional study.
    Abdulla NM; Aziz F; Blair I; Grivna M; Adam B; Loney T
    BMC Complement Altern Med; 2019 Jul; 19(1):172. PubMed ID: 31299957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration and aetiology of extended hospitalization among COVID-19 patients in United Arab Emirates.
    Shaikh NA; Fathima S; Siddique A; Abufool L; Atef Demian B; Mobushar JA; Pradeep R
    East Mediterr Health J; 2023 Nov; 29(10):783-788. PubMed ID: 37947228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covid-19 infection in pregnant women in Dubai: a case-control study.
    Hazari KS; Abdeldayem R; Paulose L; Kurien N; Almahloul Z; Mohammad H; Elgergawi TFA; Alkhanbouli M; Mahmoud K; Fazari AB; Hassan A; Bayoumi R
    BMC Pregnancy Childbirth; 2021 Sep; 21(1):658. PubMed ID: 34583679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes mellitus as a comorbidity in COVID-19 infection in the United Arab Emirates.
    Elemam NM; Hannawi H; Salmi IA; Naeem KB; Alokaily F; Hannawi S
    Saudi Med J; 2021 Feb; 42(2):170-180. PubMed ID: 33563736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Case Management Outcomes Amongst Diabetes and Hypertensive Patients in the United Arab Emirates: A Prospective Study.
    Alkhemeiri A; Al Zaabi S; Lakshmanan J; El-Khatib Z; Awofeso N
    Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36498037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characteristics and Outcomes of Patients With Diabetes Admitted for COVID-19 Treatment in Dubai: Single-Centre Cross-Sectional Study.
    Bhatti R; Khamis AH; Khatib S; Shiraz S; Matfin G
    JMIR Public Health Surveill; 2020 Dec; 6(4):e22471. PubMed ID: 33284130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological characterization of symptomatic and asymptomatic COVID-19 cases and positivity in subsequent RT-PCR tests in the United Arab Emirates.
    Al-Rifai RH; Acuna J; Al Hossany FI; Aden B; Al Memari SA; Al Mazrouei SK; Ahmed LA
    PLoS One; 2021; 16(2):e0246903. PubMed ID: 33577582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethnicity-Specific Features of COVID-19 Among Arabs, Africans, South Asians, East Asians, and Caucasians in the United Arab Emirates.
    Al Zahmi F; Habuza T; Awawdeh R; Elshekhali H; Lee M; Salamin N; Sajid R; Kiran D; Nihalani S; Smetanina D; Talako T; Neidl-Van Gorkom K; Zaki N; Loney T; Statsenko Y
    Front Cell Infect Microbiol; 2021; 11():773141. PubMed ID: 35368452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of severity and mortality among patients hospitalized with COVID-19 in Rhode Island.
    Pandita A; Gillani FS; Shi Y; Hardesty A; McCarthy M; Aridi J; Farmakiotis D; Chiang SS; Beckwith CG
    PLoS One; 2021; 16(6):e0252411. PubMed ID: 34143791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare resource utilization and direct costs of transfusion-dependent thalassemia patients in Dubai, United Arab Emirates: a retrospective cost-of-illness study.
    Alshamsi S; Hamidi S; Narci HO
    BMC Health Serv Res; 2022 Mar; 22(1):304. PubMed ID: 35248046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of COVID-19 quarantine on lifestyle indicators in the United Arab Emirates.
    AlBlooshi S; AlFalasi M; Taha Z; El Ktaibi F; Khalid A
    Front Public Health; 2023; 11():1123894. PubMed ID: 36860383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 patient characteristics and time to viral clearance: A retrospective observational study in a multiethnic population (United Arab Emirates).
    Hafez W
    J Clin Virol; 2022 Dec; 157():105297. PubMed ID: 36183547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and laboratory characteristics of patients hospitalised with COVID-19: clinical outcomes in Abu Dhabi, United Arab Emirates.
    Al Harbi M; Al Kaabi N; Al Nuaimi A; Abdalla J; Khan T; Gasmelseed H; Khan A; Hamdoun O; Weber S
    BMC Infect Dis; 2022 Feb; 22(1):136. PubMed ID: 35135491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and risk factors for mortality among COVID-19 hospitalized patients in UAE: Does ethnic origin have an impact.
    AbuRuz S; Al-Azayzih A; ZainAlAbdin S; Beiram R; Al Hajjar M
    PLoS One; 2022; 17(3):e0264547. PubMed ID: 35235580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the Sinopharm's BBIBP-CorV vaccine in preventing hospital admissions and death in infected vaccinees: Results from a retrospective study in the emirate of Abu Dhabi, United Arab Emirates (UAE).
    Ismail AlHosani F; Eduardo Stanciole A; Aden B; Timoshkin A; Najim O; Abbas Zaher W; AlSayedsaleh AlDhaheri F; Al Mazrouie S; Rizvi TA; Mustafa F
    Vaccine; 2022 Mar; 40(13):2003-2010. PubMed ID: 35193793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.